BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 22448975)

  • 1. Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesis.
    Heifetz A; Morris GB; Biggin PC; Barker O; Fryatt T; Bentley J; Hallett D; Manikowski D; Pal S; Reifegerste R; Slack M; Law R
    Biochemistry; 2012 Apr; 51(15):3178-97. PubMed ID: 22448975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the binding pocket of dual antagonist almorexant to human orexin 1 and orexin 2 receptors: comparison with the selective OX1 antagonist SB-674042 and the selective OX2 antagonist N-ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA).
    Malherbe P; Roche O; Marcuz A; Kratzeisen C; Wettstein JG; Bissantz C
    Mol Pharmacol; 2010 Jul; 78(1):81-93. PubMed ID: 20404073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward an understanding of agonist binding to human Orexin-1 and Orexin-2 receptors with G-protein-coupled receptor modeling and site-directed mutagenesis.
    Heifetz A; Barker O; Morris GB; Law RJ; Slack M; Biggin PC
    Biochemistry; 2013 Nov; 52(46):8246-60. PubMed ID: 24144388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and electrophysiological characterization of almorexant, a dual orexin 1 receptor (OX1)/orexin 2 receptor (OX2) antagonist: comparison with selective OX1 and OX2 antagonists.
    Malherbe P; Borroni E; Pinard E; Wettstein JG; Knoflach F
    Mol Pharmacol; 2009 Sep; 76(3):618-31. PubMed ID: 19542319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of the binding sites for the OX1 orexin receptor antagonist, SB-334867, using orexin/hypocretin receptor chimaeras.
    Putula J; Kukkonen JP
    Neurosci Lett; 2012 Jan; 506(1):111-5. PubMed ID: 22079339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orexin-A is composed of a highly conserved C-terminal and a specific, hydrophilic N-terminal region, revealing the structural basis of specific recognition by the orexin-1 receptor.
    Takai T; Takaya T; Nakano M; Akutsu H; Nakagawa A; Aimoto S; Nagai K; Ikegami T
    J Pept Sci; 2006 Jul; 12(7):443-54. PubMed ID: 16429482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct recognition of OX1 and OX2 receptors by orexin peptides.
    Ammoun S; Holmqvist T; Shariatmadari R; Oonk HB; Detheux M; Parmentier M; Akerman KE; Kukkonen JP
    J Pharmacol Exp Ther; 2003 May; 305(2):507-14. PubMed ID: 12606634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orexin/hypocretin receptor chimaeras reveal structural features important for orexin peptide distinction.
    Putula J; Turunen PM; Johansson L; Näsman J; Ra R; Korhonen L; Kukkonen JP
    FEBS Lett; 2011 May; 585(9):1368-74. PubMed ID: 21510948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR conformational studies of micelle-bound orexin-B: a neuropeptide involved in the sleep/awake cycle and feeding regulation.
    Miskolzie M; Lucyk S; Kotovych G
    J Biomol Struct Dyn; 2003 Dec; 21(3):341-51. PubMed ID: 14616030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
    Kristiansen K
    Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric, mutant orexin receptors show key interactions between orexin receptors, peptides and antagonists.
    Tran DT; Bonaventure P; Hack M; Mirzadegan T; Dvorak C; Letavic M; Carruthers N; Lovenberg T; Sutton SW
    Eur J Pharmacol; 2011 Sep; 667(1-3):120-8. PubMed ID: 21679703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food-induced expression of orexin receptors in rat duodenal mucosa regulates the bicarbonate secretory response to orexin-A.
    Bengtsson MW; Mäkelä K; Sjöblom M; Uotila S; Akerman KE; Herzig KH; Flemström G
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G501-9. PubMed ID: 17585016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of proestrous milieu on expression of orexin receptors and prepro-orexin in rat hypothalamus and hypophysis: actions of Cetrorelix and Nembutal.
    Silveyra P; Catalano PN; Lux-Lantos V; Libertun C
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E820-8. PubMed ID: 17122088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NMR-derived conformation of orexin-A: an orphan G-protein coupled receptor agonist involved in appetite regulation and sleep.
    Miskolzie M; Kotovych G
    J Biomol Struct Dyn; 2003 Oct; 21(2):201-10. PubMed ID: 12956605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orexin B inhibits proliferation and stimulates specialized function of cultured rat calvarial osteoblast-like cells.
    Ziolkowska A; Rucinski M; Tyczewska M; Malendowicz LK
    Int J Mol Med; 2008 Dec; 22(6):749-55. PubMed ID: 19020772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orexins and their receptors from fish to mammals: a comparative approach.
    Wong KK; Ng SY; Lee LT; Ng HK; Chow BK
    Gen Comp Endocrinol; 2011 Apr; 171(2):124-30. PubMed ID: 21216246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist ligand discrimination by the two orexin receptors depends on the expression system.
    Putula J; Turunen PM; Jäntti MH; Ekholm ME; Kukkonen JP
    Neurosci Lett; 2011 Apr; 494(1):57-60. PubMed ID: 21362456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement.
    Duxon MS; Stretton J; Starr K; Jones DN; Holland V; Riley G; Jerman J; Brough S; Smart D; Johns A; Chan W; Porter RA; Upton N
    Psychopharmacology (Berl); 2001 Jan; 153(2):203-9. PubMed ID: 11205420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model.
    Lescot E; Sopkova-de Oliveira Santos J; Colloc'h N; Rodrigo J; Milazzo-Segalas I; Bureau R; Rault S
    Proteins; 2008 Oct; 73(1):173-84. PubMed ID: 18409194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective orexin receptor antagonists.
    Lebold TP; Bonaventure P; Shireman BT
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4761-9. PubMed ID: 23891187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.